HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Shiseido

This article was originally published in The Rose Sheet

Executive Summary

Shinzo Maeda to President & CEO, pending shareholder approval at firm's ordinary general meeting and board of directors meeting in June, Shiseido announces Feb. 4. Maeda replaces Morio Ikeda, who will become director and chairman of the board. Shiseido's cosmetic sales increased 3% to $3.6 bil. (¥1=$.009), while toiletries sales dropped 4.7% to $432.7 mil., the Japanese firm reports Jan. 31. In the Americas, sales were flat at $304.4 mil. Shiseido's overall net sales increased 2.7% to $4.5 bil. in the first nine months of the firm's year, while net income jumped 16.1% to $131.3 mil. For the year, however, Shiseido anticipates recording a consolidated net loss of $133.9 mil., compared to earlier predictions of $114.7 mil. profit. Change is due to $186.9 mil. charge related to the implementation of a special early retirement incentive plan...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS012803

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel